SOLUTIONS / GLOBAL DEVELOPMENT & MARKET ACCESS
One operating model for the decisions that shape a programme.
Hope Focus helps teams decide what to do next across product type, target market, evidence strategy, quality readiness and partner delivery.
START WITH THE DIRECTION OF TRAVEL
Two journeys. The same discipline.
Select the direction that reflects your programme. The work changes by jurisdiction; the operating model stays accountable.
CHINA → GLOBAL
Build a credible route from Chinese innovation to priority markets.
Sequence markets and evidence around the product’s maturity, intended use and available data — then coordinate the work required to reach submission readiness.
Decide the order
Target-market comparison, development order and pathway logic across pharmaceuticals, devices, IVD, SaMD and combination products.
Reuse what is strong
Map existing clinical, RWD/RWE, CMC, non-clinical, quality and technical evidence to each market’s needs.
Coordinate the work
Bring specialist partners into one programme with milestones, work packages, risk ownership and clear interfaces.
GLOBAL → CHINA
Translate global innovation into a China-ready evidence and access plan.
Assess China market entry, Lecheng and real-world evidence opportunities, local clinical needs and the readiness of the product package.
Assess feasibility
Product classification, China pathway, existing evidence acceptance and local execution requirements.
Close the bridge
RWD/RWE, clinical, non-clinical, CMC, technical and quality activities needed for a credible China programme.
Activate local capability
Coordinate medical institutions, CROs, data partners and specialist regulatory support around the same plan.